Drug Inspector, Aide Caught By ACB Taking ₹20,000 Bribe

KAKINADA: Anti-Corruption Bureau (ACB) officials on Friday caught Drug Inspector Kampa Suresh Kumar of Jangareddygudem and his alleged private aide, Tadikamalla Siva Ramakrishna, red-handed while accepting a bribe of ₹20,000.

Officials said Durga Sai later visited the Jangareddygudem office and submitted all required documents to the Drug Inspector, who uploaded them online. However, the licence was allegedly delayed, following which Suresh Kumar demanded a bribe and directed the complainant to contact Siva Ramakrishna, who allegedly agreed to collect the amount on his behalf.

Unwilling to pay the bribe, the complainant approached the ACB. Acting on the complaint, ACB officials laid a trap and caught Siva Ramakrishna while receiving the bribe amount on behalf of the Drug Inspector. Both Siva Ramakrishna and Suresh Kumar were arrested and are being produced before the ACB court at Rajamahendravaram.

ACB officials said searches were continuing at the residence and office premises of Suresh Kumar. They said he joined government service as a pharmacist in 1995, was later promoted as Junior Analyst and served at Vijayawada, and was promoted as Drug Inspector in 2021. He has been posted at Jangareddygudem since October 2025.

The ACB urged the public to report instances of corruption to local ACB offices or through the toll-free number 1064, mobile number 9440440057 or email at complaints-acb@ap.gov.in, assuring confidentiality of informants.

Source : Deccan Chronicle

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre